UFP Technologies (UFPT) 16th Annual Midwest Ideas Conference summary

Company overview and business model

• Operates as a contract development and manufacturing organization (CDMO) with a focus on medical devices, serving 26 of the top 30 global medical device companies.

• Generates nearly $600 million in revenue, with $550 million from medical devices, and maintains a $2 billion market cap.

• Employs about 4,000 people across 22 locations and six development labs worldwide.

• Engages early with clients to develop innovative, high-margin products and custom manufacturing processes.

• Focuses on high-value, low average selling price, high-risk-of-failure components, especially in single-use, plastic-based medical devices.

Key technologies, products, and client relationships

• Develops and scales custom manufacturing for technologies like negative pressure wound therapy, robotic surgical drapes, and infection prevention devices.

• Partners with market leaders in infection prevention, ICU bed covers, and patient transfer products, often building custom equipment for unique needs.

• Major clients include Intuitive Surgical and Stryker, each contributing about $150 million in revenue.

• Expands value to clients by acquiring complementary businesses and technologies, such as DAS Medical, Marble Medical, and TPI.

• Maintains strong supplier relationships, providing preferential and exclusive access to materials.

Market opportunity and growth strategy

• Targets the $100 billion medical device outsourcing market, which is growing at 10–11% annually.

• Focuses on organic growth in fast-growing segments like robotic surgery and patient handling, and on strategic, accretive acquisitions.

• Since 2021, completed nine med-tech acquisitions, driving medical revenue from $132 million to $540 million, a 40% CAGR.

• Holds less than 1% market share, indicating significant room for expansion.

• Operates in a highly fragmented, regulated market with 900+ private equity-backed CDMOs.